Highlights Merck & Co., Inc. Swiss Exchange

Equities

MRK

US58933Y1055

Market Closed - Swiss Exchange Other stock markets 10:06:38 05/12/2022 pm IST			5-day change	1st Jan Change
400 ^CHF	+388.82%		-.--%	-.--%

28/06	Merck: positive opinion for Winrevair in Europe	CF
28/06	Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Merck Says European Medicines Agency's Committee Recommends Approval of Heart Disease Drug Winrevair	28/06	MT
Merck Receives Positive EU CHMP Opinion for WINREVAIR (Sotatercept) in Pulmonary Arterial Hypertension	28/06	CI
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	28/06	RE
CDC?S ACIP Unanimously Recommends Merck?s CAPVAXIVE? (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults	28/06	CI
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug	27/06	RE
Aqilion Announces the Termination of the Licensing and Collaboration Agreement with Merck for the Joint Development of the TAK1 Programme Taking Aim at Chronic Inflammation	27/06	CI
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer	27/06	CI
Merck: US approval for canine flu vaccine	26/06	CF
Merck's Animal Health Unit Says USDA Approves Dog Flu Vaccine	26/06	MT
China grants license to Merck's KEYTRUDA for stomach cancer treatment	25/06	RE
Global markets live: Shell, UBS, Boeing, Berkshire Hathaway, Exxon...	18/06
Big tech still runs the show	18/06
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	18/06	MT
Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals	18/06	MT
US FDA approves Merck's pneumococcal vaccine for adults	18/06	RE
Merck Announces U.S. FDA Approves Capvaxive (Pneumococcal 21-Valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults	18/06	CI
Merck Announces FDA Approves Merck's Keytruda (Pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma	18/06	CI
Ex-dividend day	17/06	FA
High-risk health workers can get routine Ebola vaccine, Gavi says	13/06	RE
AbbVie inks immune disorder drug licensing deal with China's FutureGen	13/06	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Merck & Co., Inc. Swiss Exchange

Equities

MRK

US58933Y1055

Highlights

Filters